These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4282925)

  • 21. Phytomitogen and neuraminidase in the treatment of Ehrlich carcinoma in mice.
    Mobley JR; Graber CD; O'Brien PH; Gale GR; Neeley B
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):155-62. PubMed ID: 4438822
    [No Abstract]   [Full Text] [Related]  

  • 22. Esters of chlorohydroxyacetone in chemotherapy of murine tumors.
    Babiarz-Tracy P; McCarthy D; Simon P; Burlingham WJ; Fondy TP
    Cancer Res; 1980 Sep; 40(9):3274-80. PubMed ID: 7427941
    [No Abstract]   [Full Text] [Related]  

  • 23. [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].
    Bratus' GG; Darchuk GF
    Eksp Onkol; 1989; 11(3):35-8. PubMed ID: 2752940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuraminidase induced loss in the transplantability of murine leukaemia L 1210, induction of immunoprotection and the transfer of induced immunity to normal DBA-2 mice by serum and peritoneal cells.
    Sethi KK; Brandis H
    Br J Cancer; 1973 Feb; 27(2):106-13. PubMed ID: 4348470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic modifications associated with 'spontaneous' malignant alterations of mouse fibroblasts propagated in vitro.
    v F Kieler J; Oda Y; Ulrich K; Willumsen BM
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):469-83. PubMed ID: 6100143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement phenomenon.
    Petrányi GG
    Haematologia (Budap); 1972; 6(3):349-56. PubMed ID: 4677588
    [No Abstract]   [Full Text] [Related]  

  • 28. [The morphofunctional characteristics of lymphoma NK/LY cells treated with concanavalin A and Vibrio cholerae neuraminidase].
    Bratus' GG; Naumenko OI; Nastenko EP; Novichenko NL
    Tsitologiia; 1990; 32(1):67-73. PubMed ID: 2375060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and use of neuraminidase-modified L1210 plasma membranes for protection against tumor growth.
    Brandt AE; Jameson AK; Pincus JH
    Cancer Res; 1981 Aug; 41(8):3077-81. PubMed ID: 7248964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
    Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
    Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
    [No Abstract]   [Full Text] [Related]  

  • 31. Surface antigen on Ehrlich ascites tumor cells.
    Pessina A; Brambilla P; Mocarelli P
    Biomedicine; 1980; 33(4):105-9. PubMed ID: 7000194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MCG101-AA, a new ascites tumour in C57 mice. 4. Influence of enzyme treatment on transplantability and some in vitro characteristics.
    Hagmar B; Ryd W
    Acta Pathol Microbiol Scand A; 1975 May; 83(3):328-38. PubMed ID: 1155101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmentation of the antibody forming cell response to neuraminidase-treated cells by myxoviruses.
    Russell PH
    Immunology; 1981 Dec; 44(4):781-7. PubMed ID: 6274794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on anti-tumor immunity. I. Homologous immunity against Ehrlich ascites tumor (acquired type of immunity against tumor).
    Soeda M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Mar; 26(12):1598-608. PubMed ID: 5232509
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential expression of murine leukemia antigen on L1210 parental and drug-resistant sublines.
    Strzadala L; Opolski A; Radzikowski C; Mihich E
    Cancer Res; 1981 Dec; 41(12 Pt 1):4934-7. PubMed ID: 7306993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor effect of lymphocyte and macrophage from mice immunized with Ehrlich ascites tumor cells.
    Sakashita T
    Mie Med J; 1971 Jan; 20(3):227-41. PubMed ID: 5558109
    [No Abstract]   [Full Text] [Related]  

  • 37. Electrophoretic mobility of Ehrlich ascites carcinoma cells grown in vitro or in vivo.
    Mayhew E
    Cancer Res; 1968 Aug; 28(8):1590-5. PubMed ID: 5673572
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
    Song CW; Levitt SH
    Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell-mediated cytotoxicity results from, but may not be critical for, primary allograft rejection.
    Walsh CM; Hayashi F; Saffran DC; Ju ST; Berke G; Clark WR
    J Immunol; 1996 Feb; 156(4):1436-41. PubMed ID: 8568245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of neuraminidase and x-rays (2 Gy and 8 Gy) on microvilli and membrane invaginations of Ehrlich ascites tumor cells in monolayer culture].
    Laudenbach G; Schachtschabel DO; Baganz O; Pfab R; Hess F
    Strahlenther Onkol; 1987 Jan; 163(1):43-9. PubMed ID: 3810476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.